Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 65Other hematologic neoplasm 5Classical hematology 5Breast 5Gynecologic 4Gastrointestinal 4Other 3Genitourinary 3Lymphoid 2Head & Neck 2Thoracic 1Sarcoma 1Plasma cell 1NET 1Myeloid 1Endocrine 1Dermatologic 1CNS 1

Conditions

Sarcoma 11Osteosarcoma 4Gastrointestinal Stromal Tumors 3Gastrointestinal Neoplasms 3Central Nervous System Neoplasms 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Oligodendroglioma 2Meningioma 2Melanoma 2Medulloblastoma 2Lymphoma 2Hemangiosarcoma 2Gliosarcoma 2Glioma 2Glioblastoma 2Ependymoma 2Brain Neoplasms 2Bone Neoplasms 2Astrocytoma 2Vulvar Neoplasms 1Vaginal Neoplasms 1Stomach Neoplasms 1Spinal Cord Neoplasms 1Radiation Injuries 1Pyloric Stenosis, Hypertrophic 1Prostatic Neoplasms 1Plexosarcoma 1Pituitary Neoplasms 1

Interventions

Cyclophosphamide 17pembrolizumab 12Doxorubicin 10fludarabine 7Irinotecan 7Blood Specimen Collection 7Temozolomide 6Gemcitabine 6Etoposide 6Radiotherapy 5Ifosfamide 5Carboplatin 5Albumin-Bound Paclitaxel 5tecogalan 4cemiplimab 4Vincristine 4Trabectedin 4Paclitaxel 4Nivolumab 4Filgrastim 4Drug Therapy 4Dexamethasone 4Bevacizumab 4pazopanib 3olaparib 3nilotinib 3dostarlimab 3aflibercept 3Therapeutics 3Taxes 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Surveys and Questionnaires × Sarcoma × Clear all
NCT06535997 2025-08-06

PRIMHADRON

Hospices Civils de Lyon

Completed
62 enrolled
LymphoidSarcoma

Chondrosarcoma, Chordoma, Carcinoma, Adenoid Cystic, Hemangiosarcoma, Lymphoma, Follicular, Neoplasms, Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡